227 related articles for article (PubMed ID: 38581562)
21. Insights into degenerative aortic valve disease.
Goldbarg SH; Elmariah S; Miller MA; Fuster V
J Am Coll Cardiol; 2007 Sep; 50(13):1205-13. PubMed ID: 17888836
[TBL] [Abstract][Full Text] [Related]
22. GATA6 Regulates Aortic Valve Remodeling, and Its Haploinsufficiency Leads to Right-Left Type Bicuspid Aortic Valve.
Gharibeh L; Komati H; Bossé Y; Boodhwani M; Heydarpour M; Fortier M; Hassanzadeh R; Ngu J; Mathieu P; Body S; Nemer M;
Circulation; 2018 Sep; 138(10):1025-1038. PubMed ID: 29567669
[TBL] [Abstract][Full Text] [Related]
23. The role of cell biology and leaflet remodeling in the progression of heart valve disease.
Xu S; Grande-Allen KJ
Methodist Debakey Cardiovasc J; 2010; 6(1):2-7. PubMed ID: 20360651
[TBL] [Abstract][Full Text] [Related]
24. [Congenital heart disease and acquired valvular lesions in pregnancy].
Horstkotte D; Fassbender D; Piper C
Herz; 2003 May; 28(3):227-39. PubMed ID: 12756480
[TBL] [Abstract][Full Text] [Related]
25. Angiogenic modulators in valve development and disease: does valvular disease recapitulate developmental signaling pathways?
Shworak NW
Curr Opin Cardiol; 2004 Mar; 19(2):140-6. PubMed ID: 15075741
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.
Roselli C; Yu M; Nauffal V; Georges A; Yang Q; Love K; Weng LC; Delling FN; Maurya SR; Schrölkamp M; Tfelt-Hansen J; Hagège A; Jeunemaitre X; Debette S; Amouyel P; Guan W; Muehlschlegel JD; Body SC; Shah S; Samad Z; Kyryachenko S; Haynes C; Rienstra M; Le Tourneau T; Probst V; Roussel R; Wijdh-Den Hamer IJ; Siland JE; Knowlton KU; Jacques Schott J; Levine RA; Benjamin EJ; Vasan RS; Horne BD; Muhlestein JB; Benfari G; Enriquez-Sarano M; Natale A; Mohanty S; Trivedi C; Shoemaker MB; Yoneda ZT; Wells QS; Baker MT; Farber-Eger E; Michelena HI; Lundby A; Norris RA; Slaugenhaupt SA; Dina C; Lubitz SA; Bouatia-Naji N; Ellinor PT; Milan DJ
Eur Heart J; 2022 May; 43(17):1668-1680. PubMed ID: 35245370
[TBL] [Abstract][Full Text] [Related]
27. Recent clinical trials in valvular heart disease.
Kiss D; Anwaruddin S
Curr Opin Cardiol; 2017 Jul; 32(4):343-347. PubMed ID: 28441151
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling.
Oury C; Servais L; Bouznad N; Hego A; Nchimi A; Lancellotti P
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420053
[TBL] [Abstract][Full Text] [Related]
29.
De Azevedo D; Geers J; Gheysens O; Dweck M; Vancraeynest D
Semin Nucl Med; 2023 Mar; 53(2):241-257. PubMed ID: 36116988
[TBL] [Abstract][Full Text] [Related]
30. Valvular heart disease: classic teaching and emerging paradigms.
Brinkley DM; Gelfand EV
Am J Med; 2013 Dec; 126(12):1035-42. PubMed ID: 24125637
[TBL] [Abstract][Full Text] [Related]
31. Surgery for valvular heart disease: a population-based study in a Brazilian urban center.
Ribeiro GS; Tartof SY; Oliveira DW; Guedes AC; Reis MG; Riley LW; Ko AI
PLoS One; 2012; 7(5):e37855. PubMed ID: 22666401
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of maternal and fetal risk in 594 pregnancies with heart disease].
Wada H; Chiba Y; Murakami M; Kawaguchi H; Kobayashi H; Kanzaki T
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Apr; 48(4):255-62. PubMed ID: 8936109
[TBL] [Abstract][Full Text] [Related]
33. Reduced sox9 function promotes heart valve calcification phenotypes in vivo.
Peacock JD; Levay AK; Gillaspie DB; Tao G; Lincoln J
Circ Res; 2010 Mar; 106(4):712-9. PubMed ID: 20056916
[TBL] [Abstract][Full Text] [Related]
34. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
35. Lifestyle patterns, genetic susceptibility, and risk of valvular heart disease: a prospective cohort study based on the UK Biobank.
Jia C; Zeng Y; Huang X; Yang H; Qu Y; Hu Y; Chen W; Yang X
Eur J Prev Cardiol; 2023 Oct; 30(15):1665-1673. PubMed ID: 37259902
[TBL] [Abstract][Full Text] [Related]
36. Valvular Heart Disease.
Kisling A; Gallagher R
Prim Care; 2024 Mar; 51(1):95-109. PubMed ID: 38278576
[TBL] [Abstract][Full Text] [Related]
37. Imaging modalities in valvular heart disease.
Aguilar F; Nesser HJ; Faletra F; De Castro S; Maron M; Patel AR; Pandian NG
Curr Cardiol Rep; 2008 Mar; 10(2):98-103. PubMed ID: 18417009
[TBL] [Abstract][Full Text] [Related]
38. Advances in percutaneous treatment for adult valvular heart disease.
Wong MC; Clark DJ; Horrigan MC; Grube E; Matalanis G; Farouque HM
Intern Med J; 2009 Jul; 39(7):465-74. PubMed ID: 19664157
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs in Valvular Heart Diseases: Biological Regulators, Prognostic Markers and Therapeutical Targets.
Nappi F; Iervolino A; Avtaar Singh SS; Chello M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830016
[TBL] [Abstract][Full Text] [Related]
40. Artificial intelligence for the echocardiographic assessment of valvular heart disease.
Nedadur R; Wang B; Tsang W
Heart; 2022 Sep; 108(20):1592-1599. PubMed ID: 35144983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
